247 related articles for article (PubMed ID: 23554932)
21. Mean platelet volume is decreased in HIV-infected women.
Qadri S; Holman S; Dehovitz J; Crystal H; Minkoff H; Lazar JM
HIV Med; 2013 Oct; 14(9):549-55. PubMed ID: 23738819
[TBL] [Abstract][Full Text] [Related]
22. Persistent high burden of invasive pneumococcal disease in South African HIV-infected adults in the era of an antiretroviral treatment program.
Nunes MC; von Gottberg A; de Gouveia L; Cohen C; Kuwanda L; Karstaedt AS; Klugman KP; Madhi SA
PLoS One; 2011; 6(11):e27929. PubMed ID: 22140487
[TBL] [Abstract][Full Text] [Related]
23. Cause-specific mortality among HIV-infected individuals, by CD4(+) cell count at HAART initiation, compared with HIV-uninfected individuals.
Wada N; Jacobson LP; Cohen M; French A; Phair J; Muñoz A
AIDS; 2014 Jan; 28(2):257-65. PubMed ID: 24105030
[TBL] [Abstract][Full Text] [Related]
24. Characteristics and outcomes of HIV-infected patients in the ICU: impact of the highly active antiretroviral treatment era.
Vincent B; Timsit JF; Auburtin M; Schortgen F; Bouadma L; Wolff M; Regnier B
Intensive Care Med; 2004 May; 30(5):859-66. PubMed ID: 14767592
[TBL] [Abstract][Full Text] [Related]
25. Association of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United States.
Murphy K; Hoover DR; Shi Q; Cohen M; Gandhi M; Golub ET; Gustafson DR; Pearce CL; Young M; Anastos K
AIDS; 2013 Sep; 27(15):2413-23. PubMed ID: 24037210
[TBL] [Abstract][Full Text] [Related]
26. Association between self-reported marijuana use and incident diabetes in women and men with and at risk for HIV.
Okafor CN; Plankey MW; Goodman-Meza D; Li M; Bautista KJ; Bolivar H; Phyllis TC; Brown TT; Shoptaw SJ
Drug Alcohol Depend; 2020 Apr; 209():107935. PubMed ID: 32109711
[TBL] [Abstract][Full Text] [Related]
27. Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
Kapogiannis BG; Soe MM; Nesheim SR; Abrams EJ; Carter RJ; Farley J; Palumbo P; Koenig LJ; Bulterys M
Clin Infect Dis; 2011 Nov; 53(10):1024-34. PubMed ID: 22002982
[TBL] [Abstract][Full Text] [Related]
28. Injection drug use and patterns of highly active antiretroviral therapy use: an analysis of ALIVE, WIHS, and MACS cohorts.
Morris JD; Golub ET; Mehta SH; Jacobson LP; Gange SJ
AIDS Res Ther; 2007 Jun; 4():12. PubMed ID: 17553140
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular risk score associations with frailty in men and women with or at risk for HIV.
Kuniholm MH; Vásquez E; Appleton AA; Kingsley L; Palella FJ; Budoff M; Michos ED; Fox E; Jones D; Adimora AA; Ofotokun I; D'souza G; Weber KM; Tien PC; Plankey M; Sharma A; Gustafson DR
AIDS; 2022 Feb; 36(2):237-347. PubMed ID: 34934019
[TBL] [Abstract][Full Text] [Related]
30. Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression.
Chen TY; Ding EL; Seage Iii GR; Kim AY
Clin Infect Dis; 2009 Nov; 49(10):1605-15. PubMed ID: 19842982
[TBL] [Abstract][Full Text] [Related]
31. Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality.
Wyatt CM; Arons RR; Klotman PE; Klotman ME
AIDS; 2006 Feb; 20(4):561-5. PubMed ID: 16470120
[TBL] [Abstract][Full Text] [Related]
32. Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection.
Butt AA; Fultz SL; Kwoh CK; Kelley D; Skanderson M; Justice AC
Hepatology; 2004 Jul; 40(1):115-9. PubMed ID: 15239093
[TBL] [Abstract][Full Text] [Related]
33. Incidence of opportunistic and other infections in HIV-infected children in the HAART era.
Gona P; Van Dyke RB; Williams PL; Dankner WM; Chernoff MC; Nachman SA; Seage GR
JAMA; 2006 Jul; 296(3):292-300. PubMed ID: 16849662
[TBL] [Abstract][Full Text] [Related]
34. Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland.
Atta MG; Fine DM; Kirk GD; Mehta SH; Moore RD; Lucas GM
Clin Infect Dis; 2007 Dec; 45(12):1625-32. PubMed ID: 18190325
[TBL] [Abstract][Full Text] [Related]
35. Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy.
Wyatt CM; Hoover DR; Shi Q; Tien PC; Karim R; Cohen MH; Goderre JL; Seaberg EC; Lazar J; Young MA; Klotman PE; Anastos K
Antivir Ther; 2011; 16(4):591-6. PubMed ID: 21685547
[TBL] [Abstract][Full Text] [Related]
36. Obstructive sleep apnea among HIV-infected men in the highly active antiretroviral therapy era: a nation-wide longitudinal cohort study in Taiwan, 2000-2011.
Chen YC; Lin CY; Li CY; Zhang Y; Ko WC; Ko NY
Sleep Med; 2020 Jan; 65():89-95. PubMed ID: 31739231
[TBL] [Abstract][Full Text] [Related]
37. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
Tai JH; Udoji MA; Barkanic G; Byrne DW; Rebeiro PF; Byram BR; Kheshti A; Carter JD; Graves CR; Raffanti SP; Sterling TR
J Infect Dis; 2007 Oct; 196(7):1044-52. PubMed ID: 17763327
[TBL] [Abstract][Full Text] [Related]
38. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.
Palella FJ; Baker RK; Moorman AC; Chmiel JS; Wood KC; Brooks JT; Holmberg SD;
J Acquir Immune Defic Syndr; 2006 Sep; 43(1):27-34. PubMed ID: 16878047
[TBL] [Abstract][Full Text] [Related]
39. Influence of gender on receipt of guideline-based antiretroviral therapy in the era of HAART.
Cocohoba JM; Althoff KN; Godfrey R; Palella FJ; Greenblatt RM
AIDS Care; 2012; 24(1):20-9. PubMed ID: 21732716
[TBL] [Abstract][Full Text] [Related]
40. The interaction between smoking status and highly active antiretroviral therapy (HAART) use on the risk of Kaposi's sarcoma (KS) in a cohort of HIV-infected men.
Luu HN; Amirian ES; Scheurer ME
Br J Cancer; 2013 Mar; 108(5):1173-7. PubMed ID: 23422755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
